Moleculin Biotech (MBRX) analyst forecast and price target
Analyst forecast
Consensus of 3 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $3.00 from $22.00 | Aug 28, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $22.00 | Mar 24, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $22.00 from $4.00 | Dec 11, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $4.00 | Sep 10, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $4.00 | Aug 27, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $4.00 | Jun 18, 2025 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $4.00 | Jun 9, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 | Mar 25, 2025 |
| Maxim Group | Upgraded | Hold → Buy | $4.00 | Mar 25, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 | Mar 24, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $8.00 | Mar 3, 2025 |
| Maxim Group | Maintained | Buy | $8.00 from $20.00 | Nov 12, 2024 |
| Roth MKM | Maintained | Buy | $40.00 | Apr 12, 2024 |
| Maxim Group | Maintained | Buy | $20.00 from $45.00 | Mar 26, 2024 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $3.00 | Dec 14, 2023 |
| Roth MKM | Maintained | Buy | $16.00 | Apr 18, 2023 |
| Oppenheimer | Maintained | Outperform | $5.00 | Mar 24, 2023 |
Frequently asked questions
Is MBRX a buy, sell, or hold?
Analysts covering Moleculin Biotech currently average a Buy rating: 3 buy, 0 hold and 0 sell, from 3 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on MBRX?
On Aug 28, 2026, HC Wainwright & Co. maintained Moleculin Biotech at Buy with a price target of $3.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.